177 related articles for article (PubMed ID: 22400986)
1. The in vitro toxicology of Swedish snus.
Coggins CR; Ballantyne M; Curvall M; Rutqvist LE
Crit Rev Toxicol; 2012 Apr; 42(4):304-13. PubMed ID: 22400986
[TBL] [Abstract][Full Text] [Related]
2. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
[TBL] [Abstract][Full Text] [Related]
3. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
4. The Swedish snus and the Sudanese toombak: are they different?
Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
[TBL] [Abstract][Full Text] [Related]
5. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P; Hodge K; Stanfill S; Zhang L; Watson C
Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity testing of extracts of a Swedish moist oral snuff.
Jansson T; Romert L; Magnusson J; Jenssen D
Mutat Res; 1991 Oct; 261(2):101-15. PubMed ID: 1922153
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
Seidenberg AB; Ayo-Yusuf OA; Rees VW
Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
10. The need for regulation of carcinogenic N-nitrosamines in oral snuff.
Djordjevic MV; Brunnemann KD; Hoffmann D
Food Chem Toxicol; 1993 Jul; 31(7):497-501. PubMed ID: 8340028
[TBL] [Abstract][Full Text] [Related]
11. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users.
Andersson G; Warfvinge G
Swed Dent J; 2003; 27(2):67-75. PubMed ID: 12856395
[TBL] [Abstract][Full Text] [Related]
12. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
13. Alteration in contractile G-protein coupled receptor expression by moist snuff and nicotine in rat cerebral arteries.
Sandhu H; Xu CB; Edvinsson L
Toxicol Appl Pharmacol; 2011 Apr; 252(2):138-49. PubMed ID: 21316381
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the mutagenicity of various types of tobacco products.
Rickert WS; Wright WG; Trivedi AH; Momin RA; Lauterbach JH
Regul Toxicol Pharmacol; 2007 Aug; 48(3):320-30. PubMed ID: 17614170
[TBL] [Abstract][Full Text] [Related]
15. Systemic Toxicity of Smokeless Tobacco Products in Mice.
Malovichko MV; Zeller I; Krivokhizhina TV; Xie Z; Lorkiewicz P; Agarwal A; Wickramasinghe N; Sithu SD; Shah J; O'Toole T; Rai SN; Bhatnagar A; Conklin DJ; Srivastava S
Nicotine Tob Res; 2019 Jan; 21(1):101-110. PubMed ID: 30085294
[TBL] [Abstract][Full Text] [Related]
16. Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts.
Yu F; Bishop E; Miazzi F; Evans R; Smart D; Breheny D; Thorne D
Mutat Res Genet Toxicol Environ Mutagen; 2024 Apr; 895():503738. PubMed ID: 38575247
[TBL] [Abstract][Full Text] [Related]
17. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
Gray JN; Breland AB; Weaver M; Eissenberg T
Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
[TBL] [Abstract][Full Text] [Related]
18. Chemical composition and carcinogenicity of smokeless tobacco.
Hoffmann D; Djordjevic MV
Adv Dent Res; 1997 Sep; 11(3):322-9. PubMed ID: 9524432
[TBL] [Abstract][Full Text] [Related]
19. Formation and analysis of tobacco-specific N-nitrosamines.
Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
[TBL] [Abstract][Full Text] [Related]
20. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
